CVI
Cardiac & Vascular Interventions of New Jersey (CVI) is a physician-owned interventional cardiology and vascular medicine practice in New Brunswick, NJ, treating PAD, venous insufficiency, varicose veins, non-healing wounds, and cardiac symptoms for individual patients via in-person and telehealth visits.
- Company typePrivate
- Founded-
- HeadquartersNew Brunswick, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What CVI does
Cardiac & Vascular Interventions of New Jersey (CVI) is a single-location, physician-owned interventional cardiology and vascular medicine practice headquartered at 303 George Street in New Brunswick, New Jersey. The practice is led by Dr. Ramzan Zakir, an interventional cardiologist who also serves as Director of Complex Coronary Interventions at Robert Wood Johnson University Hospital, and is staffed by a small clinical team that includes Dr. Aditi Malhotra Yadav (venous insufficiency and varicose veins specialist) and Samantha Guillod (APN). It serves individual adult patients presenting with peripheral arterial disease (PAD), chronic venous insufficiency (CVI), deep vein thrombosis (DVT), varicose veins, venous ulcers, non-healing wounds, chest pain, and shortness of breath — conditions affecting an addressable pool that the practice cites as roughly 8.5 million Americans with PAD and 35% of US adults with varicose veins.
The service portfolio spans diagnostic procedures (angiogram, vascular ultrasound, echocardiogram, stress testing, EKG), minimally invasive image-guided interventions (endovenous laser ablation, radiofrequency ablation, sclerotherapy including Varithena foam, VenaSeal closure, balloon angioplasty, drug-eluting stents, atherectomy, Intravascular Ultrasound–guided interventions), advanced wound care for limb salvage, and a HIPAA-compliant telehealth platform for virtual consultations and prescription management. Underlying technology is conventional interventional cardiology and vascular medicine infrastructure rather than proprietary software or AI systems.
Revenue is generated on a professional-services, fee-for-service basis: per-visit consultations and per-procedure charges billed through Medicare, Medicaid, and private insurance with patient responsibility for uncovered amounts. Go-to-market is sales-led, relying on physician referrals, hospital affiliations (Robert Wood Johnson University Hospital), organic search traffic driven by educational blog content, patient testimonials, online appointment booking, and telehealth. The practice is privately held with no disclosed external investment, parent entity, or institutional backing.
CVI firmographics
Firmographics- Name
- CVI
- Legal name
- Cardiac & Vascular Interventions of New Jersey
- Website
- https://cvinj.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cardiac & Vascular Interventions of New Jersey (CVI) is a physician-owned interventional cardiology and vascular medicine practice in New Brunswick, NJ, treating PAD, venous insufficiency, varicose veins, non-healing wounds, and cardiac symptoms for individual patients via in-person and telehealth visits.
- Ownership category
- akta.pro rank
CVI industry classification
Industry- Product category
- Interventional Cardiology & Vascular Medicine
- NAICS
- Offices of Physicians (6211), Home Health Care Services (62161)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Interventional Cardiology (PCI/Structural Heart) (HLAKABAB)
- akta.pro secondary industries
- Vascular Medicine (Peripheral Arterial/Venous Disease) (HLAKABAG), Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK)
Keywords
Where CVI is headquartered
LocationHeadquarters
- HQ city
- New Brunswick
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CVI business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Revenue model
- Medical Services Revenue: Revenue generated from patient consultations, diagnostic procedures (angiograms, vascular ultrasounds), and treatments (angioplasty, stenting, sclerotherapy, radiofrequency ablation, Varithena procedures). Billed through insurance (Medicare, Medicaid, private insurers) and patient payments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Per visit | Office Consultation |
| Other | Per procedure | Medical Procedures |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
CVI product offering
Product offeringCore offering
Cardiac & Vascular Interventions of New Jersey (CVI) is a single-location interventional cardiology and vascular specialty practice in New Brunswick, NJ that diagnoses and treats circulatory disorders including peripheral arterial disease, chronic venous insufficiency, deep vein thrombosis, varicose veins, non-healing wounds, chest pain, and shortness of breath. The practice delivers minimally invasive procedures such as endovenous ablation, IVUS-guided interventions, angioplasty, stenting, sclerotherapy (including Varithena), VenaSeal closure, and limb salvage treatments, alongside telehealth consultations and in-person office visits.
Product overview
Cardiac & Vascular Interventions of New Jersey (CVI) is a single-location interventional vascular specialty practice offering a comprehensive suite of diagnostic and treatment services for circulatory health conditions. The practice operates as a unified service offering rather than a platform-plus-modules architecture. Core services include telehealth/virtual appointments for remote consultations, diagnostic procedures (angiograms, vascular ultrasound evaluation), and minimally invasive treatments for vascular conditions including peripheral arterial disease (PAD), chronic venous insufficiency, varicose veins, deep vein thrombosis (DVT), and non-healing wounds. Treatment modalities include radiofrequency ablation, sclerotherapy (including Varithena foam sclerotherapy), endovenous laser therapy, balloon angioplasty with stenting, and advanced wound care. The practice is led by Dr. Ramzan Zakir, an interventional cardiologist and vascular specialist.
Differentiator
Problem solved
Functional benefit
Products and services
- Telehealth/Virtual Appointments Virtual healthcare consultations allowing patients to videoconference with providers from any location, receive medical care, and obtain prescriptions electronically via a HIPAA-compliant video platform with two-way HD video, digital registration, prescription management, and secure online payment. Designed for new and existing patients of the practice.
- Non-Healing Wounds Treatment Specialized treatment for slow-healing wounds on lower legs and feet caused by vascular conditions, including debridement, wound dressing, and addressing underlying circulatory problems. Targets patients at risk of amputation from infected leg ulcers.
- Leg Pain Treatment Diagnosis and treatment of leg pain caused by vascular disorders including chronic venous insufficiency, peripheral artery disease, and deep vein thrombosis. For patients experiencing claudication, leg discoloration, and leg swelling.
- Angiogram X-ray procedure using contrast dye to assess arterial blockages and evaluate blood vessel health, with potential for simultaneous treatment via catheterization. Diagnostic for vascular and coronary disease.
- PAD (Peripheral Arterial Disease) Treatment Treatment for narrowed arteries in legs due to atherosclerosis, including balloon angioplasty, stenting, medication management, and lifestyle counseling. For patients with peripheral arterial disease.
- Venous Ulcers Treatment Treatment for chronic leg ulcers caused by venous insufficiency, including sclerotherapy, endovenous laser ablation, radiofrequency ablation, and advanced wound care.
- Chest Pain Evaluation Diagnostic evaluation and treatment for chest pain, including ECG, echocardiogram, stress testing, and minimally invasive procedures like balloon angioplasty and stenting.
- Shortness of Breath Evaluation Diagnostic testing for causes of dyspnea including EKG, echocardiogram, stress testing, and nuclear stress testing to identify cardiac or pulmonary conditions.
- Varicose Veins Treatment Minimally invasive treatments for varicose veins including endovenous laser therapy, radiofrequency ablation, and sclerotherapy to restore circulation.
- Varithena Sclerotherapy FDA-approved injectable foam sclerotherapy treatment for varicose veins that expands to reach all vein walls and causes diseased veins to close and be absorbed by the body.
- Venous Insufficiency Treatment Comprehensive treatment for chronic venous insufficiency including Varithena sclerotherapy, VenaSeal vein closure, ClosureFast radiofrequency ablation, and ambulatory phlebectomy.
- Sclerotherapy Injectable chemical treatment that collapses and eliminates varicose and spider veins, including foam sclerotherapy for larger veins.
- Leg Swelling Treatment Evaluation and treatment of edema caused by vascular conditions including chronic venous insufficiency and deep vein thrombosis, using compression therapy, medication, and minimally invasive procedures.
- Radiofrequency Ablation Minimally invasive treatment using radiofrequency energy to resolve varicose veins and chronic venous insufficiency with little to no downtime.
Quantifiable outcome
- Thousands of successful angioplasty procedures performed since 2009
- +1 more outcomes
Companies that use CVI
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
CVI technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
CVI partnerships and signals
Strategic signalScale indicators4 records
Recent moves4 records
Expansion highlights4 records
CVI competitors and assessment
Company assessmentBroad incumbents
- RWJPE Heart and Vascular Institute of Central Jersey: Hospital-affiliated cardiology and vascular group where Dr. Zakir practices and directs complex coronary interventions. Comparable clinical scope and patient population, but operates as part of a large integrated health system rather than an independent specialty practice.
- Hackensack Meridian Health Heart & Vascular: Large New Jersey health system's cardiology and vascular service line covering interventional cardiology, vascular surgery, and vein care. Competes for the same regional patient population as CVI but with far greater scale and system resources.
Direct peers
- USA Vascular Centers: National network of office-based vascular centers treating PAD, venous disease, and related circulatory conditions using minimally invasive procedures. Closely aligned with CVI's PAD, venous ulcer, and limb-salvage service lines.
- Center for Vein Restoration: Largest physician-led vein treatment network in the US, operating outpatient centers focused on venous insufficiency, varicose veins, and related vascular conditions. Directly comparable to CVI in its vein-focused procedure mix and ambulatory delivery model.
- Inovia Vein Specialty Centers: Outpatient vein specialty practice offering endovenous ablation, sclerotherapy, and other varicose vein treatments in an office-based setting. Highly comparable to CVI's venous insufficiency and varicose veins offering.
- Vein Clinics of America: Multi-site outpatient practice specializing in diagnosis and treatment of vein disease, including varicose and spider veins. Directly comparable specialty and delivery model to CVI.
Regional players
- Atlantic Health System Cardiology: New Jersey-based integrated delivery network with cardiovascular services across northern and central NJ. Comparable specialty footprint but anchored to hospitals rather than free-standing office-based procedures.
- Cardiovascular Associates of the Delaware Valley: Independent cardiology group serving southern New Jersey and greater Philadelphia with interventional cardiology and vascular services. Comparable independent practice model in an adjacent regional market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
CVI social profiles
Digital presenceCVI financial estimates
Financial estimateRevenue estimate
Valuation estimate
CVI leadership team
Management profileNumber of profiles
Profiles3 records
CVI funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CVI M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CVI
What does CVI do?
Cardiac & Vascular Interventions of New Jersey (CVI) is a single-location interventional cardiology and vascular specialty practice in New Brunswick, NJ that diagnoses and treats circulatory disorders including peripheral arterial disease, chronic venous insufficiency, deep vein thrombosis, varicose veins, non-healing wounds, chest pain, and shortness of breath. The practice delivers minimally invasive procedures such as endovenous ablation, IVUS-guided interventions, angioplasty, stenting, sclerotherapy (including Varithena), VenaSeal closure, and limb salvage treatments, alongside telehealth consultations and in-person office visits.
Is CVI a public or private company?
CVI is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CVI founded?
CVI was founded in -1. It employs 1 to 10 people.
Where is CVI based?
CVI is headquartered in New Brunswick, United States, in the North America region.
How does CVI make money?
One revenue line is on record: medical Services Revenue.
Who are CVI's main competitors?
Broad incumbents on record are RWJPE Heart and Vascular Institute of Central Jersey and Hackensack Meridian Health Heart & Vascular. Direct peers are USA Vascular Centers, Center for Vein Restoration, Inovia Vein Specialty Centers and Vein Clinics of America. Regional players are Atlantic Health System Cardiology and Cardiovascular Associates of the Delaware Valley.
Does CVI have an API?
No public API is recorded for CVI.
What industry is CVI in?
CVI's product category is Interventional Cardiology & Vascular Medicine. Its primary akta.pro industry code is HLAKABAB, Interventional Cardiology (PCI/Structural Heart), with a secondary code of HLAKABAG, Vascular Medicine (Peripheral Arterial/Venous Disease). Its NAICS code is 6211 and its SIC code is 8011.